Literature DB >> 2612719

On the impact of hypertension on the prognosis of NIDDM. Results of the Schwabing GP-Program.

E Standl1, H Stiegler, R Roth, K Schulz, W Lehmacher.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2612719

Source DB:  PubMed          Journal:  Diabete Metab        ISSN： 0338-1684


× No keyword cloud information.
  5 in total

1.  Do angiotensin converting enzyme inhibitors represent a progress in hypertension care in diabetes mellitus?

Authors:  K Rett; P T Sawicki
Journal:  Diabetologia       Date:  1991-02       Impact factor: 10.122

Review 2.  Renal function changes in middle-aged and elderly Caucasian type 2 (non-insulin-dependent) diabetic patients--a review.

Authors:  A Schmitz
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

3.  Abnormal Na+/H+ antiport activity in cultured fibroblasts from NIDDM patients with hypertension and microalbuminuria.

Authors:  R Trevisan; M R Cipollina; E Duner; M Trevisan; R Nosadini
Journal:  Diabetologia       Date:  1996-06       Impact factor: 10.122

4.  UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.

Authors: 
Journal:  Diabetologia       Date:  1991-12       Impact factor: 10.122

Review 5.  Hypertension and insulin resistance. Glycaemia and insulinaemia in overweight hypertensive patients.

Authors:  B Weichenhain; H J van Kooten; E Standl
Journal:  Drugs       Date:  1993       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.